Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: B-cell Depletion in Offspring to Women With MS Under Immunomodulatory Treatment
This clinical trial update covers B-cell depletion in the offspring of women with multiple sclerosis who are on immunomodulatory therapy; th…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Bacille Calmette-Guérin (BCG) Vaccine In Radiologically Isolated Syndrome (RIS) [Phase 2]
Phase 2 clinical trial evaluating Bacille Calmette-Guérin (BCG) vaccine in radiologically isolated syndrome, a preclinical condition often l…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Pilot of the Virtual Memory Attention and Problem Solving Skills Intervention for Persons With Multiple Sclerosis (MS) [NA]
A pilot trial to evaluate a virtual cognitive training intervention (memory, attention, and problem-solving skills) for people with Multiple…
-
FDA approval · 2024-11-27FDA Approved: TIZANIDINE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for tizanidine from Unichem Pharmaceuticals (USA), Inc., approving the generic product with labeling…
-
CLINICAL_TRIALS withdrawal · 2024-11-27Clinical Trial Update: Comparison of Vigorous Versus Low Intensity Cool Room Treadmill Training in People with Multiple Sclerosis [NA]
Clinical trial evaluating vigorous versus low-intensity cool-room treadmill training in people with Multiple Sclerosis has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study
This completed population-based study investigates whether fingolimod use in people with multiple sclerosis is associated with skin cancer r…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: An International, Multicenter, Randomized, Double-Blind, Double-Masked Study of the Efficacy and Safety of BCD-132 (JSC BIOCAD, Russia) Using an Active Reference Drug (Teriflunomide) for the Treatment of Patients With Multiple Sclerosis [Phase 3]
Phase 3 randomized, double-blind trial comparing BCD-132 to teriflunomide for multiple sclerosis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Impact of Custom Assistive and Adaptive Technology in Rehabilitation [NA]
Completed clinical trial evaluating the impact of custom assistive and adaptive technology in rehabilitation and posting results.
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis [NA]
This clinical trial update indicates an ongoing study evaluating light stimulation to improve visual function in people with multiple sclero…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Home Rehabilitation As Continuity of Care in MS [NA]
Clinical trial update for a study on home rehabilitation as continuity of care in multiple sclerosis, currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Physical Function, Health and Employment for People With Multiple Sclerosis [NA]
Update on a clinical trial examining physical function, health, and employment in people with multiple sclerosis; the study is currently act…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Biomarkers in Autoimmune Disease of Nervous System
A Tongji Hospital clinical trial is recruiting to study biomarkers in autoimmune diseases of the nervous system, including Neuromyelitis Opt…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: An Observational Study of Patients Living With Chronic Neurological Diseases
An observational study update on patients living with chronic neurological diseases, including Alzheimer disease, mild cognitive impairment,…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)
A single-center clinical trial is evaluating the safety and efficacy of ublituximab in older adults with relapsing forms of multiple scleros…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis [Phase 3]
Phase 3 clinical trial evaluating Clemastine Fumarate as a remyelinating treatment for multiple sclerosis and internuclear ophthalmoplegia, …
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Providing Emotional Support Around the Point of Multiple Sclerosis Diagnosis: PrEliMS 2 [NA]
The PrEliMS 2 trial evaluating emotional support around the point of diagnosis in people with multiple sclerosis has completed. The document…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Predicting Disease Activity and Rebound Risk in MS Patients Treated With Sphingosine-1-phosphate Receptor Modulators (S1PRM)
This entry notes a recruiting clinical study in multiple sclerosis to predict disease activity and rebound risk in patients treated with S1P…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis [Phase 4]
This document reports the completion of a Phase 4 clinical trial evaluating solifenacin succinate for bladder symptoms caused by spinal cord…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Polish Version Fatigue Severity Scale
A Polish-version Fatigue Severity Scale trial is currently recruiting, sponsored by Jakub Antczak, involving patients with multiple sclerosi…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis [Phase 2]
Phase 2 trial evaluating Temelimab after Rituximab treatment in relapsing forms of multiple sclerosis has completed and results are posted. …
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: A Pilot Project for Multifidus Muscle Evaluation in Patients With Multiple Sclerosis [NA]
A pilot study evaluating multifidus muscle function in patients with multiple sclerosis has been terminated. The trial's results were posted…
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Studying Eye Movement Deficits and Cognitive Impairment in Patients with Multiple Sclerosis Using Infrared Eye Tracking and Cognitive Tests
A clinical trial update describes a study on eye movement deficits and cognitive impairment in people with Multiple Sclerosis and Internucle…
-
FDA approval · 2024-11-04FDA Approved: DIMETHYL FUMARATE — Supplemental Application (Solco Healthcare US, LLC)
FDA approves Solco Healthcare US, LLC's supplemental application for dimethyl fumarate, indicating approval of a generic version under an AN…
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: MS-NEUROPLAST: Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients with Multiple Sclerosis [NA]
This clinical trial entry notes that the MS-NEUROPLAST study is recruiting to investigate whether cognitive training can induce neuroplastic…
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: Effect of Functional Inspiratory Muscle Training in Patients with Multiple Sclerosis [NA]
A clinical trial update describing a study on functional inspiratory muscle training in people with multiple sclerosis, with the status list…